Literature DB >> 5813010

C3 inactivator of man. I. Hemolytic measurement by the inactivation of cell-bound C3.

S Ruddy, K F Austen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5813010

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  64 in total

1.  Chemotactic activity derived from interaction of factors D and B of the properdin pathway with cobra venom factor or C3B.

Authors:  S Ruddy; K F Austen; E J Goetzl
Journal:  J Clin Invest       Date:  1975-03       Impact factor: 14.808

2.  Cold urticaria. Recognition and characterization of a neutrophil chemotactic factor which appears in serum during experimental cold challenge.

Authors:  S I Wasserman; N A Soter; D M Center; K F Austen
Journal:  J Clin Invest       Date:  1977-07       Impact factor: 14.808

3.  Opsonizing activities of IgG, IgM antibodies and the C3b inactivator-cleaved third component of complement in macrophage phagocytosis.

Authors:  B Wellek; H Hahn; W Opferkuch
Journal:  Agents Actions       Date:  1976-02

4.  Isolation and characterization of rat complement factor B and its interaction with cell-bound human C3.

Authors:  M R Daha; L A van Es
Journal:  Immunology       Date:  1980-12       Impact factor: 7.397

5.  Stabilization of the classical pathway C3 convertase C42, by a factor F-42, isolated from serum of patients with systemic lupus erythematosus.

Authors:  M R Daha; H M Hazevoet; L A Vanes; A Cats
Journal:  Immunology       Date:  1980-07       Impact factor: 7.397

6.  The role of Fc and C3b receptors in phagocytosis by inflammatory polymorphonuclear leucocytes in man.

Authors:  J M Wilton; H H Renggli; T Lehner
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

7.  C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.

Authors:  K Whaley; P H Schur; S Ruddy
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

8.  Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.

Authors:  P C Leijh; M T van den Barselaar; T L van Zwet; M R Daha; R van Furth
Journal:  J Clin Invest       Date:  1979-04       Impact factor: 14.808

9.  Complement metabolism in man: hypercatabolism of the fourth (C4) and third (C3) components in patients with renal allograft rejection and hereditary, angioedema (HAE).

Authors:  C B Carpenter; S Ruddy; I H Shehadeh; H J Müller-Eberhard; J P Merrill; K F Austen
Journal:  J Clin Invest       Date:  1969-08       Impact factor: 14.808

10.  Comparative analysis of the properties and ligand binding characteristics of CspZ, a factor H binding protein, derived from Borrelia burgdorferi isolates of human origin.

Authors:  Elizabeth A Rogers; Shane V Abdunnur; John V McDowell; Richard T Marconi
Journal:  Infect Immun       Date:  2009-07-20       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.